MarginsXMarginsX
Home › Markets › Health Care › ELMD

Electromed Inc. (ELMD)

ELMD trades on NYSE in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$23.10
-5.02% on the day
Market cap
$188.8M
Micro cap
Revenue · 2026
$73.8M
+15.3% on 2025
Net income · 2026
$11.3M
15.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-06-30, https://www.sec.gov/Archives/edgar/data/1488917/000143774926028914/0001437749-26-028914-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-06-30.

Profile

FieldValue
TickerELMD on NYSE
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2011
SEC CIK0001488917
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inMN

Financials · 2026

LineValue
Revenue$73.8M
Net income$11.3M
Operating income$13.9M
Net margin15.3%
Operating margin18.8%
Revenue growth+15.3%
Cash$20.4M
Total assets$66.3M
P/E (computed)16.7×
P/S (computed)2.6×

Warning signs

Cash runway
Cash-flow positive
$15.9M cash at September 30, 2026
Share count, 1 year
-2.0%
2025-11-05 to 2026-11-03 · -4.8% over 3 years
Going-concern doubt
No
10-Q filed November 10, 2026
Insider net buying, 12 months
-$2.2M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-10
Cash and burn$15.9M cash; operating cash flow $2.5M a quarter.Report 2026-09-30
Shares outstanding8,174,008 (2026-11-03); 8,340,538 a year earlier; 8,581,677 three years earlier.Cover page 2026-11-03
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorRSM US LLP, Minneapolis, Minnesota, United StatesPCAOB Form AP 2026-09-15
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $2.2M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-09-30
$18.7M$2.8M$373K$15.9MNo debt tags$75.6M10-Q 2026-11-10
Q4 2026
2026-06-30
$19.4M$3.4M$3.0M$20.4MNo debt tags$73.8M10-K 2026-08-25
Q3 2026
2026-03-31
$18.6M$3.0M$3.5M$17.0MNo debt tags$71.8M10-Q 2026-05-12
Q2 2026
2025-12-31
$18.9M$2.8M$3.0M$13.8MNo debt tags$68.9M10-Q 2026-02-10
Q1 2026
2025-09-30
$16.9M$2.1M$169K$14.1MNo debt tags$66.2M10-Q 2026-11-10
Q4 2025
2025-06-30
$17.4M$2.2M$3.9M$15.3MNo debt tags$64.0M10-K 2026-08-25
Q3 2025
2025-03-31
$15.7M$1.9M$2.1M$15.2MNo debt tags$61.4M10-Q 2026-05-12
Q2 2025
2024-12-31
$16.3M$2.0M$3.2M$16.2MNo debt tags$59.6M10-Q 2025-02-11

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424(B)(4)
424B42010-08-13
Latest annual report
FORM 10-K
10-K2026-08-25
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-10
Latest current report
FORM 8-K
8-K2026-11-16
Latest proxy
FORM DEF 14A
DEF 14A2026-09-29

Source: SEC EDGAR submissions feed, 582 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-10.5%
1 month-12.1%
3 months-42.8%
Year to date-16.5%
1 year-7.7%
From 52-week high-47.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M
HSDTSolana Company Class A Common Stock (DE)$1.64-5.20%$103.1M
CVCapsoVision Inc.$6.47+7.30%$346.9M
VANIVivani Medical Inc. Common Stock (DE)$1.02+0.99%$92.0M
STXSStereotaxis Inc.$0.8027-4.80%$80.4M
NRXSNeuraxis Inc.$4.80-11.44%$68.1M
HYPRHyperfine Inc.$0.6101-3.05%$64.8M
OMOutset Medical Inc.$3.39-9.12%$64.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier